338220.KQ Vuno Inc.
- Market cap
- KRW 97.7B
- P/E
- -
- P/B
- 2.74x
- ROE
- -52.5%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 338220.KQ undervalued?
Graham numberThe Graham number of Vuno Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Vuno Inc. fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (-52.5%), below 10%.
ROA 0/1
Return on assets (-39.1%) is below the industry median (1.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (56.0%) is above the industry median (1.8%).
Revenue Growth 2/2
Revenue grew 61.5% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.3 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (2.7x) is above the industry median (0.9x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Vuno Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Vuno Inc.
Vuno Inc. engages in the artificial intelligence medical software development and services business. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. It also offers BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in ch…
Full company profileVuno Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Vuno Inc. annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 162M | 82.4M | 162M | 1.26B | 2.25B | 8.27B | 13.3B | 25.9B | 34.8B | 24.3B |
| Gross Profit | - | - | 180M | 1.22B | 1.92B | 7.64B | 12.2B | 25.0B | 34.1B | 23.2B |
| Operating Income | -913M | -2.67B | -6.02B | -9.72B | -19.8B | -15.4B | -18.9B | -12.5B | -4.93B | -16.6B |
| EBITDA | - | - | - | - | - | -13.9B | -13.3B | -10.9B | -3.69B | -16.4B |
| Net Income | -862M | -5.75B | -5.91B | -11.1B | -19.6B | -15.7B | -15.6B | -13.0B | -5.78B | -18.7B |
| EPS | -96 | -641 | -659 | -1,237 | -1,745 | -1,376 | -1,365 | -937 | -413 | -1,339 |
| Balance Sheet | ||||||||||
| Total Assets | 2.66B | 12.5B | 7.45B | 9.59B | 35.6B | 35.4B | 22.6B | 50.2B | 50.4B | 47.9B |
| Total Liabilities | 8.38B | 1.50B | 2.03B | 13.2B | 13.0B | 16.7B | 17.5B | 19.5B | 14.3B | 12.3B |
| Shareholders' Equity | -5.72B | 11.0B | 5.42B | -3.64B | 22.6B | 18.7B | 5.02B | 30.7B | 36.1B | 35.7B |
| Cash & Short-term Investments | 1.99B | 11.7B | 5.01B | 6.19B | 23.1B | 20.9B | 4.69B | 6.85B | 5.55B | 5.33B |
| Cash Flow | ||||||||||
| Operating Cash Flow | -873M | -1.75B | -4.87B | -7.80B | -14.8B | -16.3B | -15.5B | -10.9B | -4.68B | -14.2B |
| Capital Expenditure | 74.6M | 120M | 715M | 321M | 1.29B | 313M | 382M | 1.11B | 1.07B | 2.08B |
| Free Cash Flow | - | - | - | -8.38B | -16.4B | -16.6B | -15.9B | -12.0B | -5.75B | -16.3B |
| Ratios | ||||||||||
| ROE | - | -52.4% | -109.1% | - | -86.6% | -83.8% | -311.3% | -42.4% | -16.0% | -52.5% |
| ROA | -32.4% | -46.1% | -79.3% | -115.9% | -54.9% | -44.3% | -69.3% | -25.9% | -11.5% | -39.1% |
| Net Profit Margin | -532.8% | -6,984.3% | -3,647.5% | -883.6% | -870.0% | -189.3% | -117.7% | -50.3% | -16.6% | -77.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Vuno Inc. dividends
Vuno Inc. has not paid dividends in the last 9 fiscal years.
Who owns Vuno Inc.
- Insiders 15.71%
- Institutions 0.66%
- Public & others 83.63%
- Shares outstanding 14.0M
- Free float 11.8M
Vuno Inc. company profile
- Company name
- Vuno Inc.
- Ticker
- 338220.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 146
- Fiscal year end
- December
- Address
- 479, Gangnam-daero, Seoul, South Korea, 06536
- Phone
- 82 2 515 6646
- Website
- vuno.co
About Vuno Inc.
Vuno Inc. engages in the artificial intelligence medical software development and services business. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. It also offers BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; DeepCARS, an AI-based cardiac arrest risk management system; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. In addition, the company provides medical products under HATIV brand, such as HATIV K30, a kiosk-type medical device that measures electrocardiograms; HATIV P30, a medical ECG device; HATIV BP30, an automatic blood pressure monitoring device; and HATIV TP50T, an ear infrared thermometer device. The company was founded in 2014 and is headquartered in Seoul, South Korea.
Vuno Inc. management
3- Mr. Ye-ha LeeCEO & Executive Director · born 1978
- Mr. JunHong KimCFO & Head of Management · born 1969
- Mr. SeongHoon JooChief Technology Officer · born 1990